Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Hettig

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Proceedings [Of The] Annual Meeting. Central Society for Clinical Research (U.S.)|March 19, 2010
Result of methyl-bis (beta-chloroethyl) amine hydrochloride therapy; a preliminary report of a nitrogen mustardR A HETTIG
Archives of Internal Medicine (Chicago, Ill. : 1908)|October 29, 2010
Absorption, distribution and excretion of streptomycinJ D ADCOCK, R A HETTIG
Science (New York, N.Y.)|October 29, 2010
Studies on the toxicity of streptomycin for man; a preliminary reportR A HETTIG, J D ADCOCK
Proceedings. American Federation for Clinical Research|March 19, 2010
Studies on the absorption, distribution and excretion of streptomycinJ D ADCOCK, R A HETTIG
Proceedings. American Federation for Clinical Research|March 19, 2010
Studies of the toxicity of streptomycin for manR A HETTIG, J D ADCOCK
Arthritis and Rheumatism|January 1, 1976
Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapyE A Natelson, G S Cyprus, R A Hettig
Texas Medicine|December 1, 1971
Rational treatment of anemias in malignant diseasesE C Lynch, C P Alfrey, R A Hettig
The New England Journal of Medicine|October 21, 1971
TTP treatmentM A Kutell, C P Alfrey, R A Hettig
Hemoglobin|January 1, 1976
Hemoglobin Baylor (alpha2beta281(EF5) leu replaced by Arg)--an unstable mutant with high oxygen affinityR G Schneider, R A Hettig, M Bilunos, et al.
Annals of Internal Medicine|September 1, 1970
Acquired factor IX deficiency in the nephrotic syndromeE A Natelson, E C Lynch, R A Hettig, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Proceedings [Of The] Annual Meeting. Central Society for Clinical Research (U.S.)|March 19, 2010
Result of methyl-bis (beta-chloroethyl) amine hydrochloride therapy; a preliminary report of a nitrogen mustardR A HETTIG
Archives of Internal Medicine (Chicago, Ill. : 1908)|October 29, 2010
Absorption, distribution and excretion of streptomycinJ D ADCOCK, R A HETTIG
Science (New York, N.Y.)|October 29, 2010
Studies on the toxicity of streptomycin for man; a preliminary reportR A HETTIG, J D ADCOCK
Proceedings. American Federation for Clinical Research|March 19, 2010
Studies on the absorption, distribution and excretion of streptomycinJ D ADCOCK, R A HETTIG
Proceedings. American Federation for Clinical Research|March 19, 2010
Studies of the toxicity of streptomycin for manR A HETTIG, J D ADCOCK
Arthritis and Rheumatism|January 1, 1976
Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapyE A Natelson, G S Cyprus, R A Hettig
Texas Medicine|December 1, 1971
Rational treatment of anemias in malignant diseasesE C Lynch, C P Alfrey, R A Hettig
The New England Journal of Medicine|October 21, 1971
TTP treatmentM A Kutell, C P Alfrey, R A Hettig
Hemoglobin|January 1, 1976
Hemoglobin Baylor (alpha2beta281(EF5) leu replaced by Arg)--an unstable mutant with high oxygen affinityR G Schneider, R A Hettig, M Bilunos, et al.
Annals of Internal Medicine|September 1, 1970
Acquired factor IX deficiency in the nephrotic syndromeE A Natelson, E C Lynch, R A Hettig, et al.
Pageof 2